In a groundbreaking move, the ATP has given the green light for the use of wearable technology during competitions on both the ATP Tour and ATP Challenger Tour, effective from July 15, 2026. This decision ushers in a new era of data-driven performance enhancement and injury prevention in the world of tennis.
These wearable devices will provide players with valuable insights by tracking physical metrics such as heart rate and high-intensity load data. This information will be instrumental in analyzing both matches and training sessions. The ATP has approved devices from STATSports and Catapult, and all collected data will be integrated into ATP Tennis IQ – Wearables. This new dashboard is designed to offer players easy access to their performance analytics.
This initiative adds a new layer to ATP Tennis IQ, an analytics platform that was launched in 2023. The platform aims to democratize access to match data and insights, assisting players in their preparation and recovery processes. This move is part of ATP’s broader strategy to enhance the sport through the use of technology, data, and innovation.
Advocacy for Grand Slam Integration
Following a contentious situation at the Australian Open, Aryna Sabalenka has urged the Grand Slam tournaments to reconsider their stance on wearable technology. During the event, both she and Carlos Alcaraz were prohibited from using Whoop bands, which monitor health metrics such as heart rate variability and sleep stages. These devices are permitted at ATP and WTA events and have received approval from the International Tennis Federation. Jannik Sinner also faced a similar restriction during the tournament.
Tennis Australia has confirmed that wearables are currently not allowed at Grand Slam events, although discussions about their potential inclusion are ongoing. Sabalenka emphasized the importance of these devices for health monitoring and expressed hope that the major tournaments will change their policies. Sinner highlighted the usefulness of such data for post-match analysis, while former doubles champion Todd Woodbridge criticized the inconsistency in tennis regulations.
Comparative Analysis with Other Sports
Dr. Robby Sikka, the medical director of the Professional Tennis Players’ Association, noted that tennis lags behind other sports in adopting wearable technology. He pointed out that leagues such as the NFL, NBA, and MLB have already established frameworks for the use of such technology. The ATP’s approval of in-match wearables in 2024 is seen as a significant step towards optimizing player performance and reducing the risk of injuries.
Despite these advancements, players at Grand Slam events are still prohibited from using wearable devices, leading to frustration among athletes who wish to access their own health and performance data.